Thus, our data presented herein reveal that ZEB1‐AS1/ZEB1 regulatory axis is implicated in the proliferation and invasion ability in ESCC and targeting ZEB1‐AS1‐ZEB1 regulatory axis may be a new target for therapy of patients with ESCC. The gene discussed is ZEB1; the disease is esophageal squamous cell carcinoma.